Psoriasis Vulgaris

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2023-03-15
Clinical Trial Update: Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis [Phase 4]
A Phase 4 trial evaluating bimekizumab in psoriasis vulgaris with active psoriatic arthritis was withdrawn.